glp-1 compound news Troubling Findings in Study of Compounders FDA moves to remove GLP-1

The prosecution concluded it was more successful at maintaining target glucose control than slow acting insulin glargine U100

Further, a per-protocol analysis was performed on the basis of 31 patients who received all 3 injections in each trial phase

After putting 20 subjects under an experiment, their skin texture and complexion changed significantly after 8 weeks

From Lab to Scale: A Game-Changing Approach to Peptide Purification in GLP-1 Manufacturing In the rapidly evolving landscape of peptide therapeutics, particularly with the surge in GLP-1 receptor agonists, manufacturing efficiency has become a critical differentiator

However, as this is the only study, more high-quality research is needed